查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1139839

質子治療市場:各適應症，各產品類型，各終端用戶:全球機會分析及產業預測，2021-2031年

Proton Therapy Market By Indication, By Product Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

全球質子治療市場，2021年達4億3833萬美元，預計從2022年到2031年年複合成長率記錄13.65％，2031年達到15億7,939萬美元。

對質子治療的需求，由於癌症罹患率增加，質子治療的優點相關宣導活動的劇增，放射治療設備的技術進步，在預測期間內預計全球增加。還有患者對質子治療的關心也高，質子治療的認知度提高，也推動市場成長。可是，預計質子治療的成本高，妨礙市場成長。新興國家引進質子治療的，預計提供該市場的主要參與者有利的成長機會。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
    • 主要的投資口袋
  • 波特的五力分析
  • 主要企業的定位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • COVID-19 影響分析

第4章 質子治療市場:各適應症

  • 概要
    • 市場規模及預測
  • 頭頸椎癌症
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 中樞神經系統癌症
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 前列腺癌
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 乳癌
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 其他
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第5章 質子治療市場:各產品類型

  • 概要
    • 市場規模、預測
  • 加速器
    • 主要的市場趨勢，成長要素與機會
    • 市場規模、預測:各地區
    • 市場分析:各國分析
  • 電子束運輸系
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 電子束傳送設備
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 管嘴和影像瀏覽器
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 患者定位系統
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第6章 質子治療市場:各終端用戶

  • 概要
    • 市場規模、預測
  • 醫院
    • 主要的市場趨勢，成長要素與機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 質子治療中心
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 其他
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第7章 質子治療市場:各地區

  • 概要
    • 市場規模、預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模、預測:各適應症
    • 北美市場規模、預測:各產品類型
    • 北美市場規模、預測:各終端用戶
    • 北美市場規模、預測:各國
      • 美國
  • 歐洲
    • 主要趨勢與機會
    • 歐洲市場規模、預測:各適應症
    • 歐洲市場規模、預測:各產品類型
    • 歐洲市場規模、預測:各終端用戶
    • 歐洲市場規模、預測:各國
      • 德國
      • 法國
      • 英國
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太地區的市場規模、預測:各適應症
    • 亞太地區的市場規模、預測:各產品類型
    • 亞太地區的市場規模、預測:各終端用戶
    • 亞太地區的市場規模、預測:各國
      • 日本
      • 中國
      • 韓國
      • 其他亞太地區
  • LAMEA
    • 主要趨勢和機會
    • LAMEA的市場規模、預測:各適應症
    • LAMEA的市場規模、預測:各產品類型
    • LAMEA的市場規模、預測:各終端用戶
    • LAMEA的市場規模、預測:各國
      • 沙烏地阿拉伯

第8章 企業形勢

  • 簡介
  • 主要成功策略
  • 主要十大公司的產品製圖
  • 競爭儀表板
  • 競爭的熱圖
  • 主要的發展

第9章 企業簡介

  • ION BEAM APPLICATIONS
  • Provision Healthcare
  • HITACHI LTD.
  • MEVION MEDICAL SYSTEMS
  • OPTIVUS PROTON THERAPY INC.
  • PRONOVA SOLUTIONS LLC.
  • SUMITOMO CORPORATION
  • Siemens Ltd
  • Mirion Technologies
  • Toshiba Corp.
Product Code: A00427

The global proton therapy market was valued at $438.33 million in 2021, and is projected to reach $1579.39 million by 2031, registering a CAGR of 13.65% from 2022 to 2031.

Proton therapy is the most precise and advanced type of radiation therapy. It is widely used to treat cancer. It has a number of advantages over traditional radiation therapy, in terms of efficacy and adverse effects. It is a pleasant, non-invasive treatment that helps patients retain their quality of life and return to normal activities fast. It enables doctors to administer full or greater treatment dosages that kill primary tumors without harming healthy tissues or organs. Major limitations of photon therapy or other particle therapies are overcome by proton therapy. Advancements in technology have increased adoption of proton therapy for treatments of various cancers across the globe.

Demand for proton therapy is anticipated to increase globally during the forecast period, owing to increase in prevalence of cancer and surge in number of awareness campaigns about benefits of proton therapy and technological advancements in radiotherapy devices. Moreover, patients are eager to know more about proton therapy treatment process and increase in recognition of proton therapy drive growth of the market, globally. However, higher cost of proton therapy is anticipated to hamper the market growth. In addition, proton therapy devices are very large in size and require large space with dedicated areas. The setup cost is exclusive of the device cost, which further increases investments, thereby restraining growth of this market. Moreover, introduction of proton therapy in emerging economies is expected to offer lucrative growth opportunities for key players in the market.

The global proton therapy market is segmented into indications, product type, end user, and region. By indication, the market is divided into head & neck cancer, central nervous system cancer, prostate cancer, breast cancer, and others. According to product type, it is bifurcated into accelerator, beam transport system, beam delivery system, nozzles & image viewers, and patient positioning system. On the basis of end user market, it is divided into hospitals, proton therapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Major companies profiled in the report include Hitachi, Ltd., Ion Beam Applications S.A., Mevion Medical Systems, Mirion Technologies Ltd., Optivus Proton Therapy, Inc., Provision Healthcare, Pro Tom International, Siemens, Sumitomo Heavy Industries, Ltd., and Toshiba Corporation.

Key Benefits For Stakeholders

 This report provides an in-depth analysis of the proton therapy market with current trends and estimations from 2022 to 2031.

Geographical analysis of the market is expected to help companies to plan their strategies accordingly and take region specific decisions.

Analysis of key strategies adopted by market players is expected to provide market intelligence and help stakeholders understand competitive structure of the market.

The report analyzes market conditions in a comprehensive and quantitative manner and forecasts market trends and techniques for proton therapy applications.

Key Market Segments

By Indication

  • Head and Neck Cancer
  • CNS Cancer
  • Prostate Cancer
  • Breast Cancer
  • Others

By Product Type

  • Accelerator
  • Beam Transport System
  • Beam Delivery System
  • Nozzle and Image Viewers
  • Patient Positioning System

By End User

  • Hospitals
  • Proton Therapy Centers
  • Others

By Region

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Saudi Arabia
  • Key Market Players
    • ION BEAM APPLICATIONS
    • Provision Healthcare
    • HITACHI LTD.
    • MEVION MEDICAL SYSTEMS
    • OPTIVUS PROTON THERAPY INC.
    • PRONOVA SOLUTIONS LLC.
    • SUMITOMO CORPORATION
    • Siemens Ltd
    • Mirion Technologies
    • Toshiba Corp.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PROTON THERAPY MARKET, BY INDICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Head and Neck Cancer
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 CNS Cancer
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Prostate Cancer
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Breast Cancer
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Others
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country

CHAPTER 5: PROTON THERAPY MARKET, BY PRODUCT TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Accelerator
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Beam Transport System
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Beam Delivery System
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Nozzle and Image Viewers
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country
  • 5.6 Patient Positioning System
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market analysis by country

CHAPTER 6: PROTON THERAPY MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Proton Therapy Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: PROTON THERAPY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Indication
    • 7.2.3 North America Market size and forecast, by Product Type
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Indication
      • 7.2.5.1.2 Market size and forecast, by Product Type
      • 7.2.5.1.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Indication
    • 7.3.3 Europe Market size and forecast, by Product Type
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Indication
      • 7.3.5.1.2 Market size and forecast, by Product Type
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Indication
      • 7.3.5.2.2 Market size and forecast, by Product Type
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 U.K.
      • 7.3.5.3.1 Market size and forecast, by Indication
      • 7.3.5.3.2 Market size and forecast, by Product Type
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Rest of Europe
      • 7.3.5.4.1 Market size and forecast, by Indication
      • 7.3.5.4.2 Market size and forecast, by Product Type
      • 7.3.5.4.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Indication
    • 7.4.3 Asia-Pacific Market size and forecast, by Product Type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Indication
      • 7.4.5.1.2 Market size and forecast, by Product Type
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Indication
      • 7.4.5.2.2 Market size and forecast, by Product Type
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 South Korea
      • 7.4.5.3.1 Market size and forecast, by Indication
      • 7.4.5.3.2 Market size and forecast, by Product Type
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Rest of Asia-Pacific
      • 7.4.5.4.1 Market size and forecast, by Indication
      • 7.4.5.4.2 Market size and forecast, by Product Type
      • 7.4.5.4.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Indication
    • 7.5.3 LAMEA Market size and forecast, by Product Type
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Saudi Arabia
      • 7.5.5.1.1 Market size and forecast, by Indication
      • 7.5.5.1.2 Market size and forecast, by Product Type
      • 7.5.5.1.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 ION BEAM APPLICATIONS
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Provision Healthcare
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 HITACHI LTD.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 MEVION MEDICAL SYSTEMS
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 OPTIVUS PROTON THERAPY INC.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 PRONOVA SOLUTIONS LLC.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 SUMITOMO CORPORATION
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Siemens Ltd
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Mirion Technologies
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Toshiba Corp.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 2. PROTON THERAPY MARKET REVENUE, FOR HEAD AND NECK CANCER, BY REGION , 2021-2031,($MILLION)
  • TABLE 3. PROTON THERAPY MARKET FOR HEAD AND NECK CANCER BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 4. PROTON THERAPY MARKET REVENUE, FOR CNS CANCER, BY REGION , 2021-2031,($MILLION)
  • TABLE 5. PROTON THERAPY MARKET FOR CNS CANCER BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 6. PROTON THERAPY MARKET REVENUE, FOR PROSTATE CANCER, BY REGION , 2021-2031,($MILLION)
  • TABLE 7. PROTON THERAPY MARKET FOR PROSTATE CANCER BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 8. PROTON THERAPY MARKET REVENUE, FOR BREAST CANCER, BY REGION , 2021-2031,($MILLION)
  • TABLE 9. PROTON THERAPY MARKET FOR BREAST CANCER BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 10. PROTON THERAPY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
  • TABLE 11. PROTON THERAPY MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 12. GLOBAL PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 13. PROTON THERAPY MARKET REVENUE, FOR ACCELERATOR, BY REGION , 2021-2031,($MILLION)
  • TABLE 14. PROTON THERAPY MARKET FOR ACCELERATOR BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 15. PROTON THERAPY MARKET REVENUE, FOR BEAM TRANSPORT SYSTEM, BY REGION , 2021-2031,($MILLION)
  • TABLE 16. PROTON THERAPY MARKET FOR BEAM TRANSPORT SYSTEM BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 17. PROTON THERAPY MARKET REVENUE, FOR BEAM DELIVERY SYSTEM, BY REGION , 2021-2031,($MILLION)
  • TABLE 18. PROTON THERAPY MARKET FOR BEAM DELIVERY SYSTEM BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 19. PROTON THERAPY MARKET REVENUE, FOR NOZZLE AND IMAGE VIEWERS, BY REGION , 2021-2031,($MILLION)
  • TABLE 20. PROTON THERAPY MARKET FOR NOZZLE AND IMAGE VIEWERS BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 21. PROTON THERAPY MARKET REVENUE, FOR PATIENT POSITIONING SYSTEM, BY REGION , 2021-2031,($MILLION)
  • TABLE 22. PROTON THERAPY MARKET FOR PATIENT POSITIONING SYSTEM BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 23. GLOBAL PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 24. PROTON THERAPY MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
  • TABLE 25. PROTON THERAPY MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 26. PROTON THERAPY MARKET REVENUE, FOR PROTON THERAPY CENTERS, BY REGION , 2021-2031,($MILLION)
  • TABLE 27. PROTON THERAPY MARKET FOR PROTON THERAPY CENTERS BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 28. PROTON THERAPY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
  • TABLE 29. PROTON THERAPY MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 30. PROTON THERAPY MARKET, BY REGION, 2021-2031,($MILLION)
  • TABLE 31. NORTH AMERICA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 32. NORTH AMERICA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 33. NORTH AMERICA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 34. NORTH AMERICA PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 35. U.S. PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 36. U.S. PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 37. U.S. PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 38. EUROPE PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 39. EUROPE PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 40. EUROPE PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 41. EUROPE PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 42. GERMANY PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 43. GERMANY PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 44. GERMANY PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 45. FRANCE PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 46. FRANCE PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 47. FRANCE PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 48. U.K. PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 49. U.K. PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 50. U.K. PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 51. REST OF EUROPE PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 52. REST OF EUROPE PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 53. REST OF EUROPE PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 54. ASIA-PACIFIC PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 55. ASIA-PACIFIC PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 56. ASIA-PACIFIC PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 57. ASIA-PACIFIC PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 58. JAPAN PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 59. JAPAN PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 60. JAPAN PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 61. CHINA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 62. CHINA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 63. CHINA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 64. SOUTH KOREA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 65. SOUTH KOREA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 66. SOUTH KOREA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 70. LAMEA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 71. LAMEA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 72. LAMEA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 73. LAMEA PROTON THERAPY MARKET, BY COUNTRY, 2021-2031,($MILLION)
  • TABLE 74. SAUDI ARABIA PROTON THERAPY MARKET, BY INDICATION, 2021-2031,($MILLION)
  • TABLE 75. SAUDI ARABIA PROTON THERAPY MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
  • TABLE 76. SAUDI ARABIA PROTON THERAPY MARKET, BY END USER, 2021-2031,($MILLION)
  • TABLE 77.ION BEAM APPLICATIONS: COMPANY SNAPSHOT
  • TABLE 78.ION BEAM APPLICATIONS: OPERATING SEGMENTS
  • TABLE 79.ION BEAM APPLICATIONS: PRODUCT PORTFOLIO
  • TABLE 80.ION BEAM APPLICATIONS: NET SALES,
  • TABLE 81.ION BEAM APPLICATIONS: KEY STRATERGIES
  • TABLE 82.PROVISION HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 83.PROVISION HEALTHCARE: OPERATING SEGMENTS
  • TABLE 84.PROVISION HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 85.PROVISION HEALTHCARE: NET SALES,
  • TABLE 86.PROVISION HEALTHCARE: KEY STRATERGIES
  • TABLE 87.HITACHI LTD.: COMPANY SNAPSHOT
  • TABLE 88.HITACHI LTD.: OPERATING SEGMENTS
  • TABLE 89.HITACHI LTD.: PRODUCT PORTFOLIO
  • TABLE 90.HITACHI LTD.: NET SALES,
  • TABLE 91.HITACHI LTD.: KEY STRATERGIES
  • TABLE 92.MEVION MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • TABLE 93.MEVION MEDICAL SYSTEMS: OPERATING SEGMENTS
  • TABLE 94.MEVION MEDICAL SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 95.MEVION MEDICAL SYSTEMS: NET SALES,
  • TABLE 96.MEVION MEDICAL SYSTEMS: KEY STRATERGIES
  • TABLE 97.OPTIVUS PROTON THERAPY INC.: COMPANY SNAPSHOT
  • TABLE 98.OPTIVUS PROTON THERAPY INC.: OPERATING SEGMENTS
  • TABLE 99.OPTIVUS PROTON THERAPY INC.: PRODUCT PORTFOLIO
  • TABLE 100.OPTIVUS PROTON THERAPY INC.: NET SALES,
  • TABLE 101.OPTIVUS PROTON THERAPY INC.: KEY STRATERGIES
  • TABLE 102.PRONOVA SOLUTIONS LLC.: COMPANY SNAPSHOT
  • TABLE 103.PRONOVA SOLUTIONS LLC.: OPERATING SEGMENTS
  • TABLE 104.PRONOVA SOLUTIONS LLC.: PRODUCT PORTFOLIO
  • TABLE 105.PRONOVA SOLUTIONS LLC.: NET SALES,
  • TABLE 106.PRONOVA SOLUTIONS LLC.: KEY STRATERGIES
  • TABLE 107.SUMITOMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 108.SUMITOMO CORPORATION: OPERATING SEGMENTS
  • TABLE 109.SUMITOMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 110.SUMITOMO CORPORATION: NET SALES,
  • TABLE 111.SUMITOMO CORPORATION: KEY STRATERGIES
  • TABLE 112.SIEMENS LTD: COMPANY SNAPSHOT
  • TABLE 113.SIEMENS LTD: OPERATING SEGMENTS
  • TABLE 114.SIEMENS LTD: PRODUCT PORTFOLIO
  • TABLE 115.SIEMENS LTD: NET SALES,
  • TABLE 116.SIEMENS LTD: KEY STRATERGIES
  • TABLE 117.MIRION TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 118.MIRION TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 119.MIRION TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 120.MIRION TECHNOLOGIES: NET SALES,
  • TABLE 121.MIRION TECHNOLOGIES: KEY STRATERGIES
  • TABLE 122.TOSHIBA CORP.: COMPANY SNAPSHOT
  • TABLE 123.TOSHIBA CORP.: OPERATING SEGMENTS
  • TABLE 124.TOSHIBA CORP.: PRODUCT PORTFOLIO
  • TABLE 125.TOSHIBA CORP.: NET SALES,
  • TABLE 126.TOSHIBA CORP.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.PROTON THERAPY MARKET SEGMENTATION
  • FIGURE 2.PROTON THERAPY MARKET,2021-2031
  • FIGURE 3.PROTON THERAPY MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.PROTON THERAPY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PROTON THERAPY MARKET,BY INDICATION,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF HEAD AND NECK CANCER PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CNS CANCER PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PROSTATE CANCER PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BREAST CANCER PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 18.PROTON THERAPY MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ACCELERATOR PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF BEAM TRANSPORT SYSTEM PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF BEAM DELIVERY SYSTEM PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF NOZZLE AND IMAGE VIEWERS PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PATIENT POSITIONING SYSTEM PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 24.PROTON THERAPY MARKET,BY END USER,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF HOSPITALS PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF PROTON THERAPY CENTERS PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS PROTON THERAPY MARKET,2021-2031(%)
  • FIGURE 28.PROTON THERAPY MARKET BY REGION,2021
  • FIGURE 29.U.S. PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 32.U.K. PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 33.REST OF EUROPE PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 34.JAPAN PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 35.CHINA PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 36.SOUTH KOREA PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 37.REST OF ASIA-PACIFIC PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA PROTON THERAPY MARKET,2021-2031($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43.COMPETITIVE DASHBOARD
  • FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 45.ION BEAM APPLICATIONS.: NET SALES ,($MILLION)
  • FIGURE 46.PROVISION HEALTHCARE.: NET SALES ,($MILLION)
  • FIGURE 47.HITACHI LTD..: NET SALES ,($MILLION)
  • FIGURE 48.MEVION MEDICAL SYSTEMS.: NET SALES ,($MILLION)
  • FIGURE 49.OPTIVUS PROTON THERAPY INC..: NET SALES ,($MILLION)
  • FIGURE 50.PRONOVA SOLUTIONS LLC..: NET SALES ,($MILLION)
  • FIGURE 51.SUMITOMO CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 52.SIEMENS LTD.: NET SALES ,($MILLION)
  • FIGURE 53.MIRION TECHNOLOGIES.: NET SALES ,($MILLION)
  • FIGURE 54.TOSHIBA CORP..: NET SALES ,($MILLION)